EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry

Assel Ten, Raushan Koizhaiganova iD, Dilnaz Bissenbay, Bagila Tursynova, Zhanar Zhaxibayeva, Valentina Yu

ChemistryOpen · 2026-01 · 15 (1)

DOI: 10.1002/open.202500366 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemistryOpen, online erschienen am 19.01.2026. Verfasst von Assel Ten und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, Almaty, Kazakhstan. Hauptthemen laut MEDLINE: Piperazines, Piperazine. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interest in piperazine scaffolds continues to rise due to their broad relevance across anti‐infective, anticancer, and neuroactive research. This review examines reports published from 2014 to 2024 and organizes current developments by therapeutic class, structural modification strategy, and computational assessment. Substitution patterns involving aryl, heterocyclic, and hybrid groups show consistent effects on target affinity, selectivity, and pharmacokinetic properties. Several series demonstrate strong activity in early biological evaluation, supported by docking and pharmacodynamic trends that highlight recurring structural motifs. Synthetic approaches, including N ‐functionalization, reductive routes, cross‐coupling, CH activation, microwave‐assisted reactions, and flow‐based methods, provide diverse access to optimized derivatives. Combined interpretation of synthetic, biological, and computational results outlines reproducible structure–property relationships that guide piperazine‐focused design. Future progress is expected to arise from hybrid scaffold engineering, improved strategies for central nervous system delivery, and the integration of predictive machine‐learning methods into lead refinement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperazinesPiperazineChemistry, PharmaceuticalHumansStructure-Activity RelationshipAnti-Infective AgentsAntineoplastic Agents

Stichwörter der Autor:innen

anticancer agentsantimicrobialsantipsychoticsheterocyclic synthesispiperazineprivileged scaffoldstructure–activity relationship

Substanzen

PiperazinesPiperazineAnti-Infective AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Laboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, Almaty, Kazakhstan.
  • Faculty of Chemistry, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
  • Department of Chemistry, Kazakh National Pedagogical University named after Abai, Almaty, Kazakhstan.

ORCID-Profile: Raushan Koizhaiganova

Förderung

  • Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Ten, A., Koizhaiganova, R., Bissenbay, D., Tursynova, B., Zhaxibayeva, Z., & Yu, V. (2026). Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry. ChemistryOpen, 15(1). https://doi.org/10.1002/open.202500366

Vancouver

Ten A, Koizhaiganova R, Bissenbay D, Tursynova B, Zhaxibayeva Z, Yu V. Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry. ChemistryOpen. 2026;15(1). doi:10.1002/open.202500366

BibTeX
@article{Ten2026,
  author = {Ten, Assel and Koizhaiganova, Raushan and Bissenbay, Dilnaz and Tursynova, Bagila and Zhaxibayeva, Zhanar and Yu, Valentina},
  title = {Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry},
  journal = {ChemistryOpen},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/open.202500366}
}
Kostenlos starten →